Answers are grounded in this paper and cite their sources.
MOTIVATION: Single-cell RNA-seq captures tumor heterogeneity, but it is rarely available together with patient survival outcomes. Bulk RNA-seq cohorts provide survival data but lack direct measurements of cellular expression. RESULTS: DeSCENT generates reference-informed cellular profiles from bulk RNA-seq and combines both representations for survival prediction. We evaluated DeSCENT with three survival models on eight TCGA cancer cohorts. Compared with Bulk, DeSCENT improved average C-index and generally improved time-dependent AUC, while integrated Brier score results were mixed. External validation showed higher average C-index than all three baselines, although performance was lower than in internal evaluation. These findings support the use of cellular representations in the evaluated transcriptome-only setting. AVAILABILITY AND IMPLEMENTATION: Code: https://github.com/YonghaoZhao722/DeSCENT. Archival snapshot: doi:10.5281/zenodo.22073099. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: